Plain-English translation of NCT07752732 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying patients with severe aortic valve disease to see how many of them also have a condition called cardiac amyloidosis—where abnormal proteins build up in the heart. Instead of doing an invasive heart biopsy, this study uses several types of imaging scans (ultrasound, CT, special nuclear scans, and MRI) to detect this condition non-invasively. This research could help doctors identify and treat this hidden disease in people who might otherwise be missed.
Many patients with severe aortic valve disease may actually have cardiac amyloidosis without knowing it, which affects how their heart should be treated. Currently, doctors have to perform invasive biopsies to diagnose this condition, which carries risks. This study aims to find safer, non-invasive imaging methods that can reliably detect the disease so patients can get the right treatment.
You likely qualify if…
You likely don't qualify if…
If you join, you will undergo heart imaging tests that your doctor has already determined you need—including ultrasound, CT scans, specialized nuclear scans, and possibly MRI. These are non-invasive tests where you lie still while machines take pictures of your heart. Researchers will collect and analyze these images to look for signs of amyloidosis and track how your condition progresses over time. The study is observational, meaning researchers are watching and measuring rather than giving you new treatment.
AI-generated summary from trial data · Sep 17, 2026 · Not medical advice
Germany